What is the fair value of JNJ?

Based on inv-AI’s institutional-grade analysis, the 12-month fair value estimate for Johnson & Johnson (JNJ) is $223 (range: $201–$245). Confidence level: HIGH.

Is JNJ overvalued or undervalued?

Johnson & Johnson (JNJ) is rated Fairly Priced (High) by inv-AI. The current price is $235.27 versus a mid fair value of $223, implying -5.2% upside.

What is the JNJ price target for 2026?

inv-AI’s 2026 fair value range for Johnson & Johnson (JNJ) is $201 (bear) to $245 (bull), with a base case of $223.

Johnson & Johnson (JNJ) Valuation

Rating: Fairly Priced (High)

12-Month Fair Value: $201 – $223 – $245

Confidence: HIGH

J&J has executed well through the Stelara cliff with DARZALEX (+24%) and TREMFYA (+65%) proving the diversified portfolio thesis. At $227, stock trades in upper third of band with limited near-term upside. Risk/reward 0.51:1 is unfavorable; talc litigation ($8-25B potential) remains key variable. HOLD / TRIM on strength above $235.

View full report | All intelligence | Home